Treatment‐Related Adverse Events of Antibody‐Drug Conjugate Monotherapy in Non‐Small Cell Lung Cancer: A Systematic Review and Meta‐Analysis

Yun Fan(Zhejiang Cancer Hospital), Linjing Zhou(Zhejiang Chinese Medical University), Sini Li(Chinese Academy of Sciences), Yunfeng Tong(Wenzhou Medical University), Yunfei Chen(China University of Petroleum, East China), Le Wang(Chinese Academy of Medical Sciences & Peking Union Medical College), Jing Sun(Wenzhou Medical University), Siqi Zhou(Jiangsu University)
Thoracic Cancer
November 1, 2025
10.1111/1759-7714.70178
Cited by 3

Related Papers

Camrelizumab plus carboplatin and pemetrexed versus chemotherapy alone in chemotherapy-naive patients with advanced non-squamous non-small-cell lung cancer (CameL): a randomised, open-label, multicentre, phase 3 trial
|The Lancet Respiratory Medicine|2020|504
Design and Manufacture of 3D-Printed Batteries
|Joule|2020|305
Hydrophobic copper nanowires for enhancing condensation heat transfer
|Nano Energy|2017|242
Single cell transcriptomic analyses implicate an immunosuppressive tumor microenvironment in pancreatic cancer liver metastasis
|Nature Communications|2023|191
Methionine restriction promotes cGAS activation and chromatin untethering through demethylation to enhance antitumor immunity
|Cancer Cell|2023|113